安康无痛取环多少钱安康例假前出血,安康怀孕 出血,安康白带淡绿色怎么回事,安康私人妇科医院,安康盆腔炎 病因,安康子宫切除后阴道出血是怎么回事,安康做b超需要空腹吗

The White House announced Tuesday that official public tours of the complex will resume September 12, nearly six months after tours were suspended during the onset of the coronavirus pandemic.While the White House resumes tours, a number of social distancing guidelines will be implemented, including mandatory face coverings for all visitors over the age of 2. Tours will only operate two days a week, Friday and Saturday, from 8 to 11 a.m. Capacity for the tours will be at 18%.On a given year, the White House welcomes over 1 million visitors to the complex each year. And even with the large number of tours, the demand for tours far exceeds the supply.The White House tours are generally held away from working areas of the White House.While the White House is resuming tours, a number of other capital-area facilities have remained closed to the public since March, including the US Capitol. As of Tuesday, the National Zoo and the National Air and Space Museum in Virginia are the only Smithsonian institutions to be currently open. 1047

The Senate on Wednesday will hold a hearing regarding the safety of vaccines, which will feature appearances by Surgeon General Dr. Jerome Adams and National Institutes of Health Director Dr. Francis Collins.The hearing, hosted by the Senate HELP Committee, will discuss the role of vaccines in preventing infectious disease outbreaks and protecting public health.Wednesday's hearing will also include information on a potential COVID-19 vaccine.Top U.S. health experts like Dr. Anthony Fauci say they are cautiously optimistic that there will be enough evidence to grant Emergency Use Authorization to top vaccine candidates by the end of 2020. However, recent polls indicate that some Americans remain skeptical about vaccines.A recent CBS News poll indicates that just 21% of American voters would receive a COVID-19 if one were made available at no cost. That's down from about 30% earlier this year. Two-thirds of those polled say they feel a vaccine would be "rushed" if a vaccine were made available this year.Fauci has said that if a potential vaccine is 75% effective against the virus, it still may not be effective in promoting inoculation levels necessary for "herd immunity" in the U.S. due to Americans' ongoing skepticism about vaccines.Nine vaccine makers banded together to sign a pledge on Tuesday to say that they will not seek Emergency Use Authorization for their vaccine candidates until scientific methods prove they are safe for widespread use. 1476

The U.S. regulators who will decide the fate of COVID-19 vaccines are taking an unusual step: Asking outside scientists if their standards are high enough.The Food and Drug Administration may have to decide by year’s end whether to allow use of the first vaccines against the virus. Thursday, a federal advisory committee pulls back the curtain on that decision process, debating whether the guidelines FDA has set for vaccine developers are rigorous enough.“We will not cut corners, and we will only use science and data to make that determination,” FDA Commissioner Stephen Hahn pledged at a meeting of the Milken Institute Wednesday.Exactly how much data his agency needs to be sure a vaccine is safe and effective is a key question for the advisers. An even bigger one: If the FDA allows emergency use of a vaccine before final testing is finished, will that destroy chances of ever learning just how well that shot -- and maybe competitors still being studied -- really work?“We can’t lose sight of the fact that it is in our societal interest to see these trials to completion,” said Dr. Luciana Borio, a former FDA acting chief scientist who will be watching the advisers’ debate.Plus, multiple vaccines are being studied -- shots made with different technologies that each have pros and cons.“The first vaccine is not necessarily the best vaccine,” cautioned Dr. M. Miles Braun, a former FDA scientist now with Georgetown University School of Medicine. If the trials aren’t allowed to finish, it may be difficult or impossible to ever know for sure.It’s a critical moment in FDA’s 114-year history. The government has spent billions to race a vaccine through a research process that usually takes years, and FDA faces unprecedented pressure from the Trump administration, fueling public skepticism that politics could overrule science.Interest is so high, FDA is airing the meeting on YouTube. Here are some key issues the committee will discuss:HOW MUCH EVIDENCE IS NEEDED?FDA is requiring manufacturers to do studies of at least 30,000 people to prove if a vaccine protects and how safe it is. Those studies must include adequate numbers of people at highest risk from COVID-19 -- older adults, minorities and anyone with underlying health problems.FDA has made clear that any vaccine must be at least 50% effective. And while the studies are designed to run for two years, companies may get enough evidence the shots are protective -- in at least some people -- to stop the trials early and seek what’s called an “emergency use authorization” for wider vaccinations.Despite White House objections, the FDA told vaccine makers earlier this month not to seek that speedier review until they’ve tracked at least half their trial participants for two months. With other vaccines, that’s about the amount of time when major side effects crop up.That’s not long enough, said the head of the non-profit ECRI Institute, which reviews medical technology for hospitals and insurers. In comments submitted to the advisory committee, ECRI’s Dr. Marcus Schabacker said FDA should require six months of follow-up.“Doing any less would simply risk too much, and the consequences may be severe,” he wrote. “A weak vaccine that loses public trust could poison the well for epidemic control for many years.”WOULD EMERGENCY USE DERAIL FULL ANSWERS ABOUT VACCINES?Normally when a study ends because of evidence that a vaccine is working, the participants who got dummy shots are offered the real thing.But if FDA allows emergency use of a COVID-19 vaccine, that’s not the same as having full proof the shot works, Borio cautioned.And if the participants in the placebo group are immediately offered the real shot, researchers may not be able to get answers about all the high-risk groups in the study — or tell how long the vaccine’s protection lasts, a process expected to take many more months.But Pfizer Inc., which with Germany’s BioNTech is developing one of the leading candidates, told FDA that if it’s granted emergency use authorization, it “would have an ethical obligation” to alert study participants who got a placebo and allow them vaccine access. The company wants FDA to look into “other scientifically and statistically sound methods” to determine long-term safety and effectiveness.Pfizer’s stance is likely to face pushback. The Infectious Diseases Society of America states that FDA’s panelists “should insist” that vaccine developers “present a compelling case” for how they will complete their trials if FDA grants early authorization of their vaccine.Clearing a vaccine based on premature or faulty data “could cause more harm” by “further eroding public confidence in all vaccines,” the group said.It’s an unprecedented dilemma. The FDA has previously allowed emergency use of only one vaccine, a decades-old shot that in 2005 was authorized to prevent anthrax poisoning.This time around, multiple COVID-19 vaccines are in the pipeline. Pfizer competitor Johnson & Johnson cautioned that early FDA clearance of one vaccine could “jeopardize integrity” of other ongoing trials if patients decide to drop out to seek the first cleared shot instead.The company asked regulators to explain what options are available to ensure completion of all ongoing COVID-19 vaccine trials.WHAT ABOUT LONG-TERM SAFETY MONITORING?Even a study of 30,000 people cannot spot a side effect that only strikes 1 in 100,000. So the government is planning extra scrutiny of every COVID-19 vaccine to hit the market.At first there will be limited doses given to just certain high-risk people -- and those early recipients are to get text messages daily for the first week after vaccination, and then weekly out to six weeks, asking how they’re feeling.FDA also will be checking databases of electronic health records and insurance claims, looking for any red flags.“There’s a kind of tracking that has to take place here on a massive basis that hasn’t taken place before,” said Dr. Jesse Goodman of Georgetown University, a former director of the FDA’s vaccine and biologics center.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6274

The timelines on your Instagram accounts have probably been flooded recently with women posting black-and-white pictures of themselves.The premise of the viral trend comes as a way for women to support each other with the accompaniment of the hashtag #ChallengeAccepted in their caption.The origins of the first picture used in the trend were traced by Taylor Lorenz of The New York Times. Lorenz found that a journalist in Brazil posted the very first picture in the challenge.There had been reports that the challenge first began in order to bring awareness about femicide in Turkey, but Lorenz spoke to Instagram and tweeted that the hashtag in Turkey and the United States were unrelated. 700

The University of Cincinnati's Board of Trustees voted Tuesday morning to remove Marge Schott's name from the university's baseball stadium and another space in the school's archive library immediately."Marge Schott’s record of racism and bigotry stands at stark odds with our University’s core commitment to dignity, equity, and inclusion," UC president Neville Pinto said. "I hope this action serves as an enduring reminder that we cannot remain silent or indifferent when it comes to prejudice, hate, or inequity. More than ever, our world needs us to convert our values into real and lasting action.”The board wrote in their resolution that they stand with Pinto to fight inequality."The change we want to see starts with us," the board wrote.The UC baseball stadium was constructed in 2004 and the facility was named Marge Schott Stadium in the spring of 2006 after the Marge and Charles J. Schott Foundation made a million gift to the Richard E. Lindner Varsity Village.RELATED: Pro, college athletes want University of Cincinnati baseball stadium to be renamed amid protestsA petition was started online by former UC baseball player Jordan Ramey to rename the stadium due to Schott's many racists, homophobic and anti-Semitic remarks she made while she owned the Cincinnati Reds between 1984 and 1999.Ramey learned of the board's unanimous vote Tuesday morning on social media."It's great news," Ramey told WCPO. "You can see where coming together all races - black, white, everybody, all backgrounds - what community together can do for a community in a short notice. So this is a testament to that."UC athletic director John Cunningham told Ramey last week that there was momentum for the change."I had a good feeling about it," Ramey said. "You don't have to be a big name to make a change and that's huge."UC pitcher Nathan Moore was instrumental in helping Ramey with the petition. He spoke with Dr. Pinto on the phone Tuesday morning after the board's vote."Very overjoyed, really," Moore said. "It's a great feeling just to know the Cincinnati community, the school, our board wants to move everything in the right direction. And I think everybody is on the same page with that. To see this happening is amazing."UC baseball coach Scott Googins said he supported Moore, Ramey, and the other players who helped with the petition."I'm happy for Nate Moore and bringing this to light and the change that happened," Googins said. "I'm just supporting those guys. Obviously it's progress. I'd say that. We're making some good chances and it's progress."WCPO previously reported that a Reds employee said Schott used racial slurs to refer to black Reds players; her marketing director said she called him a "beady-eyed Jew," and at one point, she said Adolf Hitler had been a good leader before World War II."Just imagine how a Black student might feel walking past that, knowing that her amount of money in a donation made it OK for her name to be commemorated on a building here," Moore said.Ramey's petition received national attention regarding the stadium name."This is such a touchy topic people don't talk about which we should as a community," Ramey said. "This is a very important topic that people gloss over. It's very important for us to realize how fast this did happen. That all it did was coming together, unity, and somebody asking for change."Ramey said Tuesday's vote wasn't a celebration per se, but it has brought awareness quickly and is an indicator of the direction of the country."As an athlete for me personally as an athlete going through UC it was conflicting to play under that name," Ramey said. "It was. I'm going to put my all out and my teammates are going to put their all-out - we're brothers - but at the end of the day that's a conflicting situation to be put in as a black athlete at the university. I don't want that to happen for anybody else coming into the next generation."The Marge and Charles Schott Foundation previously made a statement about the petition."We can ask you to learn from Mrs. Schott's mistakes as well as her great love for Cincinnati," a statement from the Schott Foundation reads. "We fully support the decisions made by the organizations that have received grants from the Foundation."St. Ursula Academy decided previously to remove Schott's name from two of their campus facilities: a stadium and a school building.There was no immediate word from UC when the exterior letters of the stadium name will be removed. There is also a plaque at the stadium.Ramey doesn't have a preference for the new name of the stadium. He's just glad the community will help determine its direction."Alumni Field is what they are throwing around right now," Ramey said. "So Alumni Stadium that would be cool. We'll see where that goes but I'm glad that we got to where we're at today."WCPO's Jasmine Minor and Zach McAuliffe first reported this story. 4916